What's new

EMEA-003112-PIP01-21-M01

EMEA-003112-PIP01-21-M01

Jun 24, 2025 - 15:10
 0
EMEA-003112-PIP01-21-M01
EMEA-003112-PIP01-21-M01
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Da...

Next Article

EMEA-000834-PIP01-10-M01

Related Posts

Orphan designation: Ganaxolone Treatment of tuberous sclerosis, 15/10/2021 Positive

Orphan designation: Ganaxolone Treatment of tuberous sc...

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Concept paper on the need for revision of note for guid...

Jun 20, 2025  0